No Data
No Data
A Quick Look at Today's Ratings for Ultragenyx Pharmaceutical(RARE.US), With a Forecast Between $67 to $127
Ultragenyx Pharmaceutical | 10-Q: Quarterly report
Ultragenyx Pharma Price Target Raised to $75.00/Share From $72.00 by Wells Fargo
Ultragenyx Pharmaceutical Up Over 12%, on Pace for Largest Percent Increase Since January 2020 -- Data Talk
Express News | Ultragenyx Pharmaceuticals Shares Are Trading Higher After the Company Reported Better-than-expected Q2 Financial Results and Raised Its FY24 Revenue Guidance Above Estimates. Also, Cantor Fitzgerald and Wedbush Raised Their Respective Price Targets...
Wedbush Adjusts Ultragenyx Pharmaceutical's PT to $46 From $43, Keeps Neutral Rating